Welcome to the WCN 2021 Interactive Program

The congress will officially run on Central European Time (CET) - Rome Time 
To convert the congress times to your local time 
Click Here

    Please note that all sessions will run at their scheduled time and be followed by a LIVE Q&A/Discussion at the end

     The viewing of sessions, cannot be accessed from this conference calendar. All sessions are accessible via the Virtual Platform

213 Sessions

  • Teaching Course (8) (8)
  • Scientific Session: MT (Main Topics) (7) (7)
  • Free Communication (6) (6)
  • Plenary Lecture (3) (3)
  • Regional Symposium Session (1) (1)
  • Scientific Session: T (Topics) (7) (7)
  • Sponsored Symposium (5) (5)
  • TC Workshops (1) (1)
  • Short Break (2) (2)
  • Break, Poster Viewing and Exhibition Visit (3) (3)
Main Topic A
Main Topic B
Main Topic C
Topic A
Topic B
Topic C
Teaching Course A
Teaching Course B
Teaching Course C
Free Communication A
Free Communication B
Free Communication C
Industry 1
Industry 2
Industry 3
  • 08:00
  • 09:00
  • 10:00
  • 11:00
  • 12:00
  • 13:00
  • 14:00
  • 15:00
  • 16:00
  • 17:00
  • 18:00
  • 19:00
  • Session Time
    08:00 - 10:00
    Session Type
    TC Workshops
    Session Title
    Session Description
    NEUROSONOGRAPHY: MUSCLE AND NERVE Ultrasound examination of muscle and nerve, one of recently developed neuroimaging methods, usually supports or confirms the diagnosis suspected by clinical neurological examination. It is widely applied in patients with peripheral nerve/muscle disorders because of its repeatability, non-invasiveness, and easiness of performing. In this session, we will briefly describe ultrasonography of muscle/nerve, and will show that its outcomes in association with electrophysiological and MRI findings help us make a diagnosis and select the treatment in patients with peripheral neuropathy or muscular disorders. VASCULAR NEUROSONOLOGY Ultrasound based methods- especially Color Codes Duplex Sonography- are today the basic screening tools for extra- und intracranial occlusive disease in symptomatic and asymptomatic patients. The diagnosis and follow-up -after treatment-of Carotid and Vertebral Artery Disease and of Intracranial Stenosis and Occlusion will be described, also in correlation with reference methods like MR- or CT-angiography. High resolution Ultrasound is also essential in the diagnosis of Non-Atherosclerotic Vasculopathies like Dissection and Giant Cell Arteriitis.
  • Session Time
    09:00 - 10:15
    Session Type
    Sponsored Symposium
    Session Description
    How to get away with MS: the 3 key leverages in disease management This session consists of three topics as follow: • “Creative Writing”: a cognitive enhancing perspective chaired by Giacomo Pinelli and Emilio Portaccio Cognitive decline is esteemed as a major debilitating symptom of Multiple Sclerosis (Ms), especially deficits in episodic memory and processing speed. Therapeutic arts have demonstrated considerable benefits for people facing a variety of chronic illnesses. Cognitive Health is fundamental to provide the correct balance for Multiple Sclerosis patients. It can be improved by several activities such as creative writing which helps people’s lives by keeping the mind active. Creative writing engages patient’s mind, piques creativity, sparks curiosity and stimulates critical thinking. Therapeutic arts are also a method for those with MS to connect with the world around them, helping to reduce feelings of isolation and loneliness. • Motor activity and cognitive function: the winning combination by Marcello Moccia and Claudia Fink Individuals with Multiple Sclerosis (MS) regularly show deficits in motor and cognitive functions. In particular, MS patients experience several difficulties with balance, gait and disfunction in cognitive processing speed. These symptoms can occur simultaneously, affecting the rehabilitation outcomes. In order to improve MS people’s life and to reduce the common symptoms, rehabilitation activities are fundamental. A key strategy to face MS and to ameliorate the disease management is a double approach to enhance both motor activities and cognitive functions.  • The inside-out approach: living Ms through emotions by Marta Radaelli and Damiano Tullio Multiple sclerosis can affect not just the body but also the emotions. MS can cause behavioural and emotional symptoms and a variety of factors can contribute to them. Remaining physically and mentally active may help regulate mood swings. The right combination of medication, clinical support, counselling and healthy lifestyle habits represent a good strategy to manage MS. Mindfulness and yoga can contribute to control emotions and can provide a healthy balance in MS people’s life. 
  • Session Time
    11:00 - 11:30
    Session Type
    Sponsored Symposium
    Session Description
    Janssen Neuroscience Introducing PONVORY® (Ponesimod): A New Treatment to Help Address the Unmet Needs of active RMS Introducing PONVORY® (ponesimod) • Product characteristics • OPTIMUM Phase III trial: PONVORY® vs teriflunomide • Study design • Clinical efficacy • Safety profile • Prescribing PONVORY® • PONVORY® dosing • Summary
  • Session Time
    14:00 - 15:30
    Session Type
    Sponsored Symposium
    Session Description
    Eculizumab as a new therapeutic option in rare neurological diseases This symposium aims to: - Spread the knowledge of a pathophysiologic mechanism that not many clinicians know properly, but that is proven to be one of the trigger causes of NMOSD (Neuromyelitis Optica Spectrum Disorder) and gMG (generalized Myasthenia Gravis), two immune mediated rare neurological diseases. - Present data for eculizumab on both diseases and highlight innovation in therapeutic environment thanks to the discussion with experts.
  • Session Time
    14:00 - 15:10
    Session Type
    Sponsored Symposium
    Session Description
    Advancing MS Care: A New Opportunity in High Efficacy Therapy Join this symposium to learn about the key data that have led to the EMA approval of the subcutaneous use of natalizumab, gain practical insights into using this new route of administration in clinical practice, and keep up-to-date on the latest evidence to maximize the safe, effective use of natalizumab. The faculty will provide three presentations on the latest advances in treatment with natalizumab followed by a live question-and-answer session. During the session, the online audience can ask questions to the expert panel.
  • Session Time
    14:00 - 15:30
    Session Type
    Sponsored Symposium
    Session Description
    Envisioning a more inclusive, diverse and equitable global migraine landscape: are we making progress? During this symposium, we will consider the myriad social determinants of health in general and – focusing on migraine specifically – critique the current state of diversity in clinical studies. We will also review what the latest data tell us about the efficacy and tolerability of monoclonal antibodies targeting the calcitonin gene-related peptide pathway (CGRP mAbs) for migraine prevention across diverse patient subgroups, including different ethnicities, migraine characteristics and comorbidities. We hope you will join us as we attempt to address this important question: are we making progress towards a more inclusive, diverse, and equitable global migraine landscape?